Cargando…

Natural killer cells efficiently target multiple myeloma clonogenic tumor cells

The multiple myeloma (MM) landscape has changed in the last few years, but most patients eventually relapse because current treatment modalities do not target clonogenic stem cells, which are drug-resistant and can self-renew. We hypothesized that side population (SP) cells represent myeloma clonoge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leivas, Alejandra, Risueño, Ruth M., Guzmán, Alma, Sánchez-Vega, Laura, Pérez, Manuel, Megías, Diego, Fernández, Lucía, Alonso, Rafael, Pérez-Martínez, Antonio, Rapado, Inmaculada, Martínez-López, Joaquín
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423695/ https://www.ncbi.nlm.nih.gov/pubmed/33693963 http://dx.doi.org/10.1007/s00262-021-02901-y

Ejemplares similares

Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma
por: Leivas, Alejandra, et al.
Publicado: (2016)

NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma
por: Leivas, Alejandra, et al.
Publicado: (2021)

Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells
por: Cornet-Masana, Josep Maria, et al.
Publicado: (2016)

Enhancement of clonogenicity of human multiple myeloma by dendritic cells
por: Kukreja, Anjli, et al.
Publicado: (2006)

XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells
por: Moreno-Martínez, Daniel, et al.
Publicado: (2014)

Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2023)

Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma
por: Rodríguez-García, Alba, et al.
Publicado: (2022)

Microbial antigens-loaded myeloma cells enhance Th2 cell proliferation and myeloma clonogenicity via Th2–myeloma cell interaction
por: Tian, Faqing, et al.
Publicado: (2019)

Clonogenic Multiple Myeloma Cells have Shared stemness Signature Associated with Patient Survival
por: Reghunathan, Renji, et al.
Publicado: (2013)

Clonogenic Assay of Gastric Adenocarcinoma Stem Cells: Clonogenic Assay, Stomach Cancer
por: Kim, Hoon Kyo, et al.
Publicado: (1987)

Isolation of Functional SARS-CoV-2 Antigen-Specific T-Cells with Specific Viral Cytotoxic Activity for Adoptive Therapy of COVID-19
por: García-Ríos, Estéfani, et al.
Publicado: (2022)

Differences of Clonogenic Mesenchymal Stem Cells on Immunomodulation of Lymphocyte Subsets
por: Martínez-Peinado, Pascual, et al.
Publicado: (2018)

In vitro Natural Killer Cell Immunotherapy for Medulloblastoma
por: Fernández, Lucia, et al.
Publicado: (2013)

Telomerase Inhibition Targets Clonogenic Multiple Myeloma Cells through Telomere Length-Dependent and Independent Mechanisms
por: Brennan, Sarah K., et al.
Publicado: (2010)

Bortezomib Reduces the Tumorigenicity of Multiple Myeloma via Downregulation of Upregulated Targets in Clonogenic Side Population Cells
por: Nara, Miho, et al.
Publicado: (2013)

Loss of p53 enhances the tumor-initiating potential and drug resistance of clonogenic multiple myeloma cells
por: Chang, Yu-Tai, et al.
Publicado: (2023)

P840: ASSESSMENT OF CONVENTIONAL TRANSLOCATIONS AND IG REARRANGEMENTS IN THE DIAGNOSIS OF MULTIPLE MYELOMA PATIENTS USING A TARGETED CAPTURE-HYBRIDIZATION RNA SEQUENCING PANEL.
por: Buenache Cuenda, Natalia, et al.
Publicado: (2023)

Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse Model
por: Escobedo-Cousin, Michelle, et al.
Publicado: (2015)

Evidence that multiple myeloma may be regulated by homeostatic control mechanisms: correlation of changes in the number of clonogenic myeloma cells in vitro with clinical response.
por: Maitland, J. A., et al.
Publicado: (1990)

Fluorescence discrimination between diploid cells on their RNA content: a possible distinction between clonogenic and non-clonogenic cells.
por: Watson, J. V., et al.
Publicado: (1977)

Clonogenicity: Holoclones and Meroclones Contain Stem Cells
por: Beaver, Charlotte M., et al.
Publicado: (2014)

Clonogenic cell survival in cryopreserved human tumour cells.
por: Selby, P. J., et al.
Publicado: (1981)

GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy
por: Fernández, Lucía, et al.
Publicado: (2019)

MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia
por: Morales, María Luz, et al.
Publicado: (2019)

P1425: ACTIVATED AND EXPANDED NATURAL KILLER CELLS TRANSDUCED WITH AN NKG2D CHIMERIC ANTIGEN RECEPTOR AGAINST ACUTE MYELOID LEUKEMIA
por: Córdoba, L., et al.
Publicado: (2022)

S256: HLA-E/NKG2A CHECKPOINT DRIVES MULTIPLE MYELOMA RESISTANCE TO CAR-NK THERAPY
por: Encinas, Jessica, et al.
Publicado: (2023)

Natural Killer Cells in the Malignant Niche of Multiple Myeloma
por: Venglar, Ondrej, et al.
Publicado: (2022)

Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells
por: Schibler, Jeanine, et al.
Publicado: (2016)

Human tumour clonogenicity in agar is improved by cell-free ascites.
por: Uitendaal, M. P., et al.
Publicado: (1983)

Robustness of Clonogenic Assays as a Biomarker for Cancer Cell Radiosensitivity
por: Matsui, Toshiaki, et al.
Publicado: (2019)

Droplet Microfluidics for the ex Vivo Expansion of Human Primary Multiple Myeloma Cells
por: Carreras, Pilar, et al.
Publicado: (2020)

Effect of host-cell interactions on clonogenic carcinoma cells in human malignant effusions.
por: Buick, R. N., et al.
Publicado: (1980)

An artefact in clonogenic assays of bleomycin cytotoxicity.
por: Twentyman, P. R.
Publicado: (1977)

Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy
por: Fernández, Adrián, et al.
Publicado: (2021)

Primary explants of the postnatal thymus allow the expansion of clonogenic thymic epithelial cells that constitute thymospheres
por: Ocampo-Godinez, Juan M., et al.
Publicado: (2023)

A comparison of human tumour-cell clonogenicity in methylcellulose and agar culture.
por: Buick, R. N., et al.
Publicado: (1980)

Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay.
por: Simmonds, A. P., et al.
Publicado: (1984)

Metformin suppresses pediatric acute myeloid leukemia cell viability and clonogenicity
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2014)

Sunitinib effectively reduces clonogenic acute myeloid leukemia cells in vitro
por: Ahmed, Farid, et al.
Publicado: (2014)

Notch3 marks clonogenic mammary luminal progenitor cells in vivo
por: Lafkas, Daniel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ceqgvp1p80p151deel88gfm657